Purpura with ulcerative skin lesions and mixed cryoglobulinemia in a quiescent hepatitis B virus carrier

Internal Medicine

Volumn 53, Issue 2, 2014, Pages 115-119

  Yamazaki, Tomoyuki ^a   Akimoto, Tetsu ^a   Okuda, Kousuke ^b   Sugase, Taro ^a,b   Takeshima, Eri ^a   Numata, Akihiko ^a   Morishita, Yoshiyuki ^a   Iwazu, Yoshitaka ^a   Yoshizawa, Hiromichi ^a   Komada, Takanori ^a   Iwazu, Kana ^a   Saito, Osamu ^a   Takemoto, Fumi ^a   Muto, Shigeaki ^a   Kusano, Eiji ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Okuda Clinic   (Japan)

Author keywords

Entecavir; Hepatitis B; Mixed cryoglobulinemia; Purpura; Reactivation

Indexed keywords

ENTECAVIR; FRESH FROZEN PLASMA; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; PREDNISOLONE; VIRUS DNA;

ACUTE HEART FAILURE; AGED; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CRYOGLOBULINEMIA; DEATH; DRUG DOSE REDUCTION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMMUNOELECTROPHORESIS; PLASMAPHERESIS; PURPURA; SKIN ULCER;

AGED; ANTIVIRAL AGENTS; COMBINED MODALITY THERAPY; CRYOGLOBULINEMIA; CRYOGLOBULINS; DNA, VIRAL; FEMALE; GUANINE; HEPATITIS B ANTIBODIES; HEPATITIS B ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; PLASMAPHERESIS; PREDNISOLONE; PURPURA; RENAL INSUFFICIENCY, CHRONIC; SKIN ULCER;

EID: 84892622375     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.53.1203     Document Type: Article

References (30)

1. Lamprecht P, Gause A, Gross WL. Cryoglobulinemic vasculitis. Arthritis Rheum 42: 2507-2516, 1999.
2. Iannuzzella F, Vaglio A, Garini G. Management of hepatitis C virus-related mixed cryoglobulinema. Am J Med 123: 400-408, 2010.
3. Akimoto T, Otake T, Tanaka A, et al. Steroid treatment in patients with membranous nephropathy and hepatitis B virus surface antigenemia: a report of two cases. Clin Exp Nephrol 15: 289-293, 2011.
4. Pasquet F, Combarnous F, Macgregor B, et al. Safety and efficacy of rituximab treatment for vasculitis in hepatitis B virus-associated type II cryoglobulinemia: a case report. J Med Case Reports 6: 39, 2012.
5. Kiyomoto H, Hitomi H, Hosotani Y, et al. The effect of combination therapy with interferon and cryofiltration on mesangial proliferative glomerulonephritis originating from mixed cryoglobulinemia in chronic hepatitis C virus infection. Ther Apher 3: 329-333, 1999.
6. Monti G, Galli M, Invernizzi F, et al. Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. QJ Med 88: 115-126, 1995.
7. Trejo O, Ramos-Casals M, García-Carrasco M, et al. Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) 80: 252-262, 2001.
8. Löhr H, Goergen B, Weber W, Gödderz W, Meyer Zum, Büschenfelde KH, Gerken G. Mixed cryoglobulinemia type II in chronic hepatitis B associated with HBe-minus HBV mutant: cellular immune reactions and response to interferon treatment. J Med Virol 44: 330-335, 1994.
9. Levo Y, Gorevic PD, Kassab HJ, Zucker-Franklin D, Franklin EC. Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 296: 1501-1504, 1977.
10. Kawakami T, Ooka S, Mizoguchi M, Soma Y, Yamazaki M. Remission of hepatitis B virus-related cryoglobulinemic vasculitis with entecavir. Ann Intern Med 149: 911-912, 2008.
11. Enomoto M, Nakanishi T, Ishii M, Tamori A, Kawada N. Entecavir to treat hepatitis B-associated cryoglobulinemic vasculitis. Ann Intern Med 149: 912-913, 2008.
12. Vladareanu AM, Ciufu C, Neagu AM, et al. The impact of hepatitis viruses on chronic lymphoproliferative disorders-preliminary results. J Med Life 3: 320-327, 2010.
13. Shalit M, Wollner S, Levo Y. Cryoglobulinemia in acute type-A hepatitis. Clin Exp Immunol 47: 613-616, 1982.
14. Inman RD, Hodge M, Johnston ME, Wright J, Heathcote J. Arthritis, vasculitis, and cryoglobulinemia associated with relapsing hepatitis A virus infection. Ann Intern Med 105: 700-703, 1986.
15. Bonomo L, Casato M, Afeltra A, Caccavo D. Treatment of idiopathic mixed cryoglobulinemia with alpha interferon. Am J Med 83: 726-730, 1987.
16. Nityanand S, Holm G, Lefvert AK. Immune complex mediated vasculitis in hepatitis B and C infections and the effect of antiviral therapy. Clin Immunol Immunopathol 82: 250-257, 1997.
17. Cacoub P, Costedoat-Chalumeau N, Lidove O, Alric L. Cryoglobulinemia vasculitis. Curr Opin Rheumatol 14: 29-35, 2002.
18. Vassilopoulos D, Calabrese LH. Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies. Arthritis Rheum 46: 585-597, 2002.
19. Firpi RJ, Nelson DR. Management of viral hepatitis in hematologic malignancies. Blood Rev 22: 117-126, 2008.
20. Fallahian F, Alavian SM, Fallahian V, Zamani F. Impact of immunosuppression and chemotherapy on reactivation of viral hepatitis. Saudi J Kidney Dis Transpl 21: 621-627, 2010.
21. Chou CK, Wang LH, Lin HM, Chi CW. Glucocorticoid stimulates hepatitis B viral gene expression in cultured human hepatoma cells. Hepatology 16: 13-18, 1992.
22. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 45: 507-539, 2007.
23. Vassilopoulos D. Should we routinely treat patients with autoimmune/ rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? Yes. Eur J Intern Med 22: 572-575, 2011.
24. Osborn M. Safety and efficacy of entecavir for the treatment of chronic hepatitis B. Infect Drug Resist 4: 55-64, 2011.
25. Ghany MG, Doo EC. Antiviral resistance and hepatitis B therapy. Hepatology 49 (5 Suppl): S174-S184, 2009.
26. Gorevic PD, Kassab HJ, Levo Y, et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 69: 287-308, 1980.
27. Dammacco F, Sansonno D, Piccoli C, Tucci FA, Racanelli V. The cryoglobulins: an overview. Eur J Clin Invest 31: 628-638, 2001.
28. Mori Y, Kishimoto N, Imai Y, et al. Cryofiltration and oral corticosteroids provide successful treatment for an elderly patient with cryoglobulinemic glomerulonephritis associated with hepatitis C virus infection. Intern Med 39: 564-569, 2000.
29. Furst DE. Serum immunoglobulins and risk of infection: how low can you go? Semin Arthritis Rheum 39: 18-29, 2008.
30. Akimoto T, Ando Y, Ito C, Muto S, Kusano E, Asano Y. Effect of plasmapheresis as initial monotherapy in a case of anti-neutrohil cytoplasmic autoantibody positive crescentic glomerulonephritis. ASAIO J 45: 509-513, 1999.